Chat with us, powered by LiveChat Current | Lhasa Limited

Current

Science of Stability 2026

Where the world’s leading stability experts present the latest advances in stability science   We are delighted to be co-hosting the annual Science of Stability conference for the third year with FreeThink Technologies as it returns for its 10th year! The conference will be back in Europe this year on 27-29 April 2026 at the […]

Science of Stability 2026 Read More »

SOT 65th Annual Meeting and ToxExpo

Experience shared knowledge with Lhasa Limited at SOT 2026 in San Diego The upcoming 65th annual meeting has an engaging lineup with three days dedicated to featuring scientific research and exhibtor-hosted sessions, alongside poster presentations and social events. The event showcases the latest advancements in toxicology and brings together a community of research organisations, regulatory

SOT 65th Annual Meeting and ToxExpo Read More »

Lhasa nitrosamine webinar series: Can nitrosamine be formed?

In the first of our 2026 nitrosamine series webinars we discover how in silico solutions support the risk assessment and mitigation of nitrosamine formation in the drug product. Nitrosamine risk assessment within our solution Zeneth, evaluates a query compound and relevant excipients under a set of reaction conditions known to cause nitrosation reactions. In this

Lhasa nitrosamine webinar series: Can nitrosamine be formed? Read More »

Argentina Pharmaceutical Science Symposium: From Predictive Science to Regulation

Save the date: Uncover best practices and new insights in chemical safety decision-making with Lhasa   Coming to Argentina on 13 March 2026, register now!   Lhasa Limited is pleased to announce that we will host a symposium in Buenos Aires, Argentina in March 2026. For our trip to South America for a co-hosted event with our subsidiary,

Argentina Pharmaceutical Science Symposium: From Predictive Science to Regulation Read More »

Colombia Pharmaceutical Science Symposium: From Predictive Science to Regulation

Save the date: Uncover best practices and new insights in chemical safety decision-making with Lhasa   Coming to Colombia on 10 March 2026!   Lhasa Limited is pleased to announce that we will host a symposium in Bogotá, Colombia in March 2026. For our trip to South America to co-host an event with our subsidiary,

Colombia Pharmaceutical Science Symposium: From Predictive Science to Regulation Read More »

ICH S1B(R1) industry and regulatory best practice for confident carcinogenicity assessment (in Japanese)

This webinar is a replay designed for our Japanese-speaking scientific community, with presentations available as recordings featuring embedded Japanese subtitles. The ICH S1B(R1) addendum is a globally recognised guideline that introduces a weight-of-evidence (WoE) approach to assessing the carcinogenic potential of pharmaceuticals.  It helps pharmaceutical organisations determine whether a two-year rat carcinogenicity study would provide

ICH S1B(R1) industry and regulatory best practice for confident carcinogenicity assessment (in Japanese) Read More »

10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit

The 10th Impurities: Genotoxic, Nitrosamine & Beyond Summit I #Egenotoxic 2026 is one of the most respected and widely attended gatherings in the field of pharmaceutical impurity control. Trusted by leading experts, regulators, and innovators across the industry, this renowned event is where the global pharma community comes together to tackle the most pressing challenges

10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit Read More »

Forced degradation problem solving (in Japanese)

強制分解の問題解決 This session will be hosted in Japanese or with Japanese subtitles. We are excited to host this webinar all about supporting forced degradation studies with in silico tools as part of your workflow. Hosted by Business Partnerships Satoshi Mashiko, with Senior Scientist Jonathan Lockett, this session covers four case studies demonstrating how in silico solution Zeneth

Forced degradation problem solving (in Japanese) Read More »

Lhasa Nitrosamine webinar series 2026

In Silico Approaches to Nitrosamine Risk Assessment — 2026 Webinar Series Nitrosamines continue to be one of the most challenging cross-functional issues facing the pharmaceutical industry, touching safety, quality, process development, and regulatory strategy. This webinar series explores how in silico tools can support confident nitrosamine risk assessment in the pharmaceutical product lifecycle. Throughout 2026,

Lhasa Nitrosamine webinar series 2026 Read More »